Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688073 Bide Pharmatech
- 41.69
- +1.12+2.76%
Market Closed Apr 24 15:00 CST
3.79BMarket Cap31.04P/E (TTM)
42.91High40.31Low19.19KlotVolume42.29Open40.57Pre Close79.49MTurnover4.44%Turnover Ratio32.27P/E (Static)90.88MShares61.6652wk High1.86P/B1.80BFloat Cap28.5052wk Low48.68Limit Up43.23MShs Float112.07Historical High32.46Limit Down6.41%Amplitude28.50Historical Low0.90Dividend TTM41.42Avg Price9.65KlotAsk2.16%Div YieldTTM100Lot Size8.07KlotBid
Bide Pharmatech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 12.83%296.37M | 0.93%1.1B | 0.79%811.38M | 1.83%532.21M | 4.05%262.67M | 30.94%1.09B | 36.78%805.01M | 41.76%522.63M | 42.58%252.46M | 37.55%833.83M |
| Operating revenue | 12.83%296.37M | 0.93%1.1B | 0.79%811.38M | 1.83%532.21M | 4.05%262.67M | 30.94%1.09B | 36.78%805.01M | 41.76%522.63M | 42.58%252.46M | 37.55%833.83M |
| Total operating cost | 8.92%245.52M | -0.92%931.88M | 6.48%696.95M | 11.35%456.33M | 10.82%225.41M | 42.38%940.55M | 42.55%654.53M | 41.87%409.83M | 44.04%203.4M | 34.46%660.6M |
| Operating cost | 2.78%164.97M | -1.31%646.52M | -0.80%477.31M | 3.92%321.95M | 12.70%160.52M | 41.25%655.12M | 48.26%481.15M | 55.13%309.8M | 54.28%142.43M | 51.37%463.8M |
| Operating tax surcharges | 26.62%1.3M | 30.54%6.71M | 47.13%4.1M | 14.27%2.44M | 220.82%1.03M | 29.79%5.14M | 15.59%2.79M | 86.65%2.14M | 260.13%319.58K | 50.38%3.96M |
| Operating expense | 2.91%32.36M | -0.21%126.79M | 6.53%94.32M | 8.87%60.64M | 21.23%31.44M | 37.03%127.06M | 36.20%88.54M | 34.08%55.69M | 30.26%25.93M | 18.28%92.73M |
| Administration expense | 31.12%32.32M | -4.10%114.65M | 13.56%81.02M | 20.92%53.23M | 16.13%24.65M | 66.23%119.55M | 40.35%71.35M | 25.90%44.02M | 23.22%21.23M | 12.39%71.92M |
| Financial expense | 92.48%-574.65K | 26.10%-21.84M | 82.50%-5.33M | 58.12%-11.98M | -185.64%-7.65M | -65.33%-29.55M | -86.41%-30.44M | -312.24%-28.6M | -238.38%-2.68M | -456.31%-17.87M |
| -Interest expense (Financial expense) | 162.17%2.25M | 31.04%3.32M | 165.54%4.23M | 234.38%3.4M | 98.01%856.54K | 16.95%2.53M | -9.98%1.59M | -18.79%1.02M | 64.76%432.57K | 134.12%2.16M |
| -Interest Income (Financial expense) | 77.85%-1.62M | 20.94%-22.12M | 14.61%-18.15M | 7.15%-13.39M | 0.55%-7.32M | -217.80%-27.98M | -1,502.51%-21.26M | -2,197.81%-14.42M | -1,447.61%-7.36M | -152.24%-8.81M |
| Research and development | -1.79%15.14M | -6.60%59.05M | 10.65%45.52M | 12.23%30.05M | -4.60%15.42M | 37.23%63.23M | 25.79%41.14M | 45.02%26.78M | 66.05%16.16M | 32.08%46.07M |
| Credit Impairment Loss | -649.11%-2.48M | 21.37%-3.93M | 21.45%-3.62M | 31.01%-2.62M | 88.14%-330.96K | -12.44%-4.99M | -72.01%-4.61M | -30.77%-3.79M | -89.45%-2.79M | -37.50%-4.44M |
| Asset Impairment Loss | -24.05%-8.6M | -85.22%-33.83M | -146.90%-21.22M | -213.14%-12.42M | -201.36%-6.93M | -143.67%-18.26M | -5.03%-8.6M | 45.32%-3.97M | 49.04%-2.3M | 21.07%-7.5M |
| Other net revenue | ||||||||||
| Fair value change income | 243.20%1.75M | 124.92%3.15M | 108.99%1.27M | 97.38%-323.5K | -136.43%-1.22M | -2,623.06%-12.63M | -170.06%-14.12M | -573.92%-12.33M | ---516.59K | ---463.89K |
| Invest income | 152.80%1.1M | -56.94%1.62M | -47.58%1.51M | -11.31%967.79K | 946.85%435.24K | 6,211.19%3.76M | 6,310.68%2.88M | 329.19%1.09M | --41.58K | -85.40%59.58K |
| -Including: Investment income associates | --184.48K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | -44.31%240.68K | 95.20%856.35K | 623.10%833.4K | 636.79%610.65K | --432.18K | --438.71K | --115.25K | --82.88K | ---- | ---- |
| Other revenue | -82.14%276.17K | 47.52%10.34M | 46.12%9.09M | -51.95%1.98M | 888.90%1.55M | -35.37%7.01M | -12.47%6.22M | 117.05%4.13M | -37.81%156.39K | 162.63%10.84M |
| Operating profit | 38.32%43.14M | 17.14%148.33M | -22.72%102.29M | -34.62%64.07M | -28.54%31.19M | -26.26%126.63M | 9.92%132.37M | 40.08%98.01M | 44.92%43.64M | 49.80%171.73M |
| Add:Non operating Income | 99.23%272.81K | 1,111.91%725.29K | 41.02%334.77K | 1,357.75%197.04K | 1,223.84%136.93K | 48.42%59.85K | 522.17%237.4K | -47.49%13.52K | -38.20%10.34K | -88.50%40.32K |
| Less:Non operating expense | 333.82%63.07K | 50.45%1.04M | -65.65%230.78K | -96.95%17.67K | -96.22%14.54K | 38,112.74%692.24K | 175,825.21%671.82K | 325,082.52%578.53K | 3,732,203.98%384.43K | -99.59%1.81K |
| Total profit | 38.45%43.35M | 17.48%148.02M | -22.39%102.39M | -34.06%64.25M | -27.64%31.31M | -26.65%126M | 9.53%131.93M | 39.22%97.44M | 43.60%43.27M | 49.94%171.77M |
| Less:Income tax cost | 141.74%12.66M | 74.31%30.59M | -3.87%18.54M | -10.42%12.42M | -17.46%5.24M | -31.98%17.55M | -14.04%19.28M | 28.16%13.86M | 34.83%6.34M | 51.89%25.8M |
| Net profit | 17.71%30.69M | 8.28%117.43M | -25.56%83.85M | -37.98%51.84M | -29.39%26.07M | -25.71%108.45M | 14.92%112.65M | 41.24%83.58M | 45.22%36.93M | 49.60%145.97M |
| Net profit from continuing operation | 17.71%30.69M | 8.28%117.43M | -25.56%83.85M | -37.98%51.84M | -29.39%26.07M | -25.71%108.45M | 14.92%112.65M | 41.24%83.58M | 45.22%36.93M | 49.60%145.97M |
| Less:Minority Profit | ---- | ---- | ---- | ---- | ---- | ---1.13M | ---751.06K | ---227.35K | ---- | ---- |
| Net profit of parent company owners | 17.71%30.69M | 7.17%117.43M | -26.05%83.85M | -38.15%51.84M | -29.39%26.07M | -24.94%109.57M | 15.69%113.4M | 41.63%83.81M | 45.22%36.93M | 49.60%145.97M |
| Earning per share | ||||||||||
| Basic earning per share | 17.24%0.34 | 9.09%1.32 | -24.80%0.94 | -36.96%0.58 | -29.27%0.29 | -38.89%1.21 | 15.74%1.25 | 41.54%0.92 | -21.15%0.41 | -2.94%1.98 |
| Diluted earning per share | 17.24%0.34 | 9.09%1.32 | -24.80%0.94 | -36.96%0.58 | -29.27%0.29 | -38.89%1.21 | 15.74%1.25 | 41.54%0.92 | -21.15%0.41 | -2.94%1.98 |
| Other composite income | 313.56%724.1K | -679.98%-1.64M | 139.13%3.37M | 101.96%376.36K | 97.59%-339.06K | 103.69%282.99K | 42.39%-8.62M | -234.98%-19.18M | -17,499.71%-14.1M | -770.19%-7.68M |
| Other composite income of parent company owners | 313.56%724.1K | -679.98%-1.64M | 139.13%3.37M | 101.96%376.36K | 97.59%-339.06K | 103.69%282.99K | 42.39%-8.62M | -234.98%-19.18M | -17,499.71%-14.1M | -770.19%-7.68M |
| Total composite income | 22.08%31.42M | 6.49%115.78M | -16.15%87.23M | -18.93%52.22M | 12.73%25.74M | -21.38%108.73M | 25.25%104.03M | 20.49%64.41M | -9.93%22.83M | 40.09%138.29M |
| Total composite income of parent company owners | 22.08%31.42M | 5.40%115.78M | -16.75%87.23M | -19.21%52.22M | 12.73%25.74M | -20.56%109.85M | 26.15%104.78M | 20.92%64.63M | -9.93%22.83M | 40.09%138.29M |
| Total composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---1.13M | ---751.06K | ---227.35K | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.